AMDULO Trademark

Trademark Overview


On Thursday, May 16, 2019, a trademark application was filed for AMDULO with the United States Patent and Trademark Office. The USPTO has given the AMDULO trademark a serial number of 79261511. The federal status of this trademark filing is REGISTERED as of Tuesday, November 26, 2019. This trademark is owned by Glaxo Group Limited. The AMDULO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines
amdulo

General Information


Serial Number79261511
Word MarkAMDULO
Filing DateThursday, May 16, 2019
Status700 - REGISTERED
Status DateTuesday, November 26, 2019
Registration Number5917450
Registration DateTuesday, November 26, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 10, 2019

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 23, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type11 - Company
AddressGB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type11 - Company
AddressGB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type11 - Company
AddressGB

Trademark Events


Event DateEvent Description
Thursday, June 27, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB
Wednesday, July 3, 2019LIMITATION FROM ORIGINAL APPLICATION ENTERED
Tuesday, July 23, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, July 27, 2019APPLICATION FILING RECEIPT MAILED
Thursday, August 1, 2019ASSIGNED TO EXAMINER
Monday, August 5, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 21, 2019NOTICE OF PUBLICATION
Tuesday, September 10, 2019PUBLISHED FOR OPPOSITION
Tuesday, November 26, 2019REGISTERED-PRINCIPAL REGISTER
Wednesday, July 19, 2023CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, May 23, 2025NEW REPRESENTATIVE AT IB RECEIVED
Thursday, December 26, 2019GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Thursday, January 23, 2020FINAL DISPOSITION PROCESSED
Thursday, January 23, 2020FINAL DISPOSITION NOTICE SENT TO IB
Friday, February 7, 2020NOTIFICATION PROCESSED BY IB